Research News

WASHINGTON (June 14, 2017) - Today some patients suffering with mantle cell lymphoma, a type of blood cancer, can be treated with a pill called ibrutinib, forgoing conventional chemotherapy. However, many are developing a resistance to this treatment.

Adam Friedman, M.D., Associate Professor of Dermatology at the GW School of Medicine and Health Sciences, wrote an article for the Huffington Post on avoiding ultraviolet radiation.

George Washington University (GW) researchers received a $2.2 million grant from the National Cancer Institute to uncover why certain cancer types increase whereas others are unchanged or even decrease in those with HIV infection.